1. The Oral Iron Chelator Deferiprone Decreases Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS). (April 2017) Authors: Merkel, D.; Soffer, S.; Filanovsky, K.; Fibach, E.; Dana, M.; Mittelman, M.; Nagler, A.; Rachmilewitz, E.A. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗